Skip to main content
. 2013 May 8;8:116. doi: 10.1186/1748-717X-8-116

Table 2.

Comparison of patient characteristics by treatment assignment (N=725)

Variable All Patients (%) PORT
Pa
Yes No
Gender
 
 
 
0.029
 Female
68(9)
16(6)
52(11)
 
 Male
657(91)
242(94)
415(89)
 
Age
 
 
 
0.004
 < 65
564(78)
216(84)
348(75)
 
 ≥65
161(22)
42(16)
119(25)
 
Tumor length
 
 
 
0.012
 < 5cm
391(54)
123(48)
268(57)
 
 ≥5cm
334(46)
135(52)
199(43)
 
pT-category
 
 
 
0.137
 T1-2
123(17)
42(16)
81(17)
 
 T3
546(75)
198(77)
348(75)
 
 T4
56(8)
18(7)
38(8)
 
pN-category
 
 
 
0.682
 N1
351(49)
121(47)
230(49)
 
 N2
227(31)
86(33)
141(30)
 
 N3
147(20)
51(20)
96(21)
 
LNMR
 
 
 
0.983
 < 0.25
582(81)
207(80)
375(80)
 
 ≥0.25
143(19)
51(20)
92(20)
 
Tumor differentiation
 
 
 
0.469
 High (G1)
90(12)
35(13)
55(12)
 
 Moderate (G2)
479(66)
176(68)
303(65)
 
 Low (G3)
156(22)
49(19)
107(23)
 
POCT
 
 
 
<0.001
 Yes
262(36)
167(65)
95(20)
 
 No 463(64) 91(35) 372(80)  

aX2p value; LNMR, lymph-node metastatic ratio; PORT, postoperative radiation therapy; POCT, postoperative chemotherapy.